Indian Journal of Critical Care Medicine

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Related articles

VOLUME 22 , ISSUE 7 ( 2018 ) > List of Articles

BRIEF COMMUNICATION

CD14+ monocytic cytokines: Impact on outcome in severely injured patients

Amit Gupta, Kapil Dev Soni, Biplap Mishra

Keywords : Interleukin-1 beta, interleukin-6, interleukin-8, monocytes, trauma, tumor necrosis factor-alpha

Citation Information : Gupta A, Soni K D, Mishra B. CD14+ monocytic cytokines: Impact on outcome in severely injured patients. Indian J Crit Care Med 2018; 22 (7):528-532.

DOI: 10.4103/ijccm.IJCCM_442_17

License: CC BY-ND 3.0

Published Online: 00-07-2018

Copyright Statement:  Copyright © 2018; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Introduction: Trauma is one of the leading causes of mortality worldwide. Trauma patients, who presented to the hospital casualty department within 24 h of injury, further admitted to the Surgical Intensive Care Unit were enrolled in this study. Materials and Methods: The aim was to study the peripheral blood monocyte activity to produce tumor necrosis factor (TNF-α), interleukin-1 (IL-1) β, IL-6, and IL-8 in severely injured patients after trauma. Result: A total of 28 polytrauma patients were enrolled and observed that the levels of TNF-α, IL-1 β, IL-6, and IL-8 were signifi cantly decreased and levels of IL-8 were increased in the fatal patients compared to the healthy controls. Conclusion: After trauma, an immediate hyperactivation of circulating monocytes is rapidly followed by a substantial paralysis of cell function. Decreased activity of monocytes can be used to identify potential fatal immunological disruption. Since immunological disruption occurs before clinical symptoms; our study proposes an immunological prognostication score for trauma victims.


PDF Share
  1. World Health Organization. Global Status Report on Road Safety 2015: Road Safety Targets and the Sustainable Development Goals. World Health Organization, Geneva, Switzerland: WHO Press; 2015.
  2. Patel A, Krebs E, Andrade L, Rulisa S, Vissoci JR, Staton CA. The epidemiology of road traffic injury hotspots in Kigali, Rwanda from police data. BMC Public Health 2016;16:697.
  3. GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015;385:117-71.
  4. Lenz A, Franklin GA, Cheadle WG. Systemic inflammation after trauma. Injury 2007;38:1336-45.
  5. Volpin G, Cohen M, Assaf M, Meir T, Katz R, Pollack S. Cytokine levels (IL-4, IL-6, IL-8 and TGFβ) as potential biomarkers of systemic inflammatory response in trauma patients. Int Orthop 2014;38:1303-9.
  6. Giannoudis PV, Hildebrand F, Pape HC. Inflammatory serum markers in patients with multiple trauma. Can they predict outcome? J Bone Joint Surg Br 2004;86:313-23.
  7. Barnett-Vanes A, Sharrock A, Birrell MA, Rankin S. A single 9-colour flow cytometric method to characterise major leukocyte populations in the rat: Validation in a model of LPS-induced pulmonary inflammation. PLoS One 2016;11:e0142520.
  8. Woodcock T, Morganti-Kossmann MC. The role of markers of inflammation in traumatic brain injury. Front Neurol 2013;4:18.
  9. Kirchhoff C, Biberthaler P, Mutschler WE, Faist E, Jochum M, Zedler S. Early down-regulation of the pro-inflammatory potential of monocytes is correlated to organ dysfunction in patients after severe multiple injury: A cohort study. Crit Care 2009;13:R88.
  10. Spolarics Z, Siddiqi M, Siegel JH, Garcia ZC, Stein DS, Denny T, et al. Depressed interleukin-12-producing activity by monocytes correlates with adverse clinical course and a shift toward th2-type lymphocyte pattern in severely injured male trauma patients. Crit Care Med 2003;31:1722-9.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.